According to the interesting work by Liu WS and colleagues (70), strategy which systematically establishes a score utilizing CXCR3 and its ligands abundances in TME to predict tumor metastasis during NK cell-based ACT and radiotherapy combined therapy may be beneficial and promising. The gene discussed is CXCR3; the disease is neoplasm.